In a historic shift, FDA transitions regulatory pathway for insulin and other biologics, meaning products deemed ‘biosimilar’ will be able to compete more easily with brands, in theory lowering prices.
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
